Sugi Predict

Sugi Predict / Compounds / SCHEMBL18238554

SCHEMBL18238554

SCHEMBL18238554

CC(C)c1ncc2[nH]c(=O)[nH]c2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 2/20 0.56
▸ DYRK1B Q9Y463 2/20 0.56
▸ IDH1 O75874 1/20 0.41
▸ PDE3B Q13370 16/20 0.40
▸ PDE3A Q14432 16/20 0.40
▸ PRKD3 O94806 2/20 0.40
▸ MAP4K4 O95819 2/20 0.40
▸ RET P07949 2/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ GSK3A P49840 2/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ RPS6KA3 P51812 2/20 0.40
▸ CDK5 Q00535 2/20 0.40
▸ MAP4K2 Q12851 2/20 0.40
▸ AURKB Q96GD4 2/20 0.40
▸ CLK4 Q9HAZ1 2/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ JAK2 O60674 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11904050 0.76 TYRO3 (0.61) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL30479256 0.73 TYRO3 (0.42) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL18168235 0.72 TYRO3 (1.00) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL31465446 0.72 TYRO3 (0.61) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL29488789 0.72 TYRO3 (0.61) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL29502006 0.72 TYRO3 (1.00) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL18865818 0.71 USP1 (0.55) —
SCHEMBL28671355 0.71 TYRO3 (0.56) TYRO3DYRK1BIDH1PDE3BPDE3A
SCHEMBL18865716 0.70 USP1 (0.48) TYRO3DYRK1B
SCHEMBL31139261 0.70 TYRO3 (0.54) TYRO3DYRK1BIDH1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO INC (US) 2023-01-05 — — US disclosed
US-20190290771-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2019-09-26 — — US disclosed
US-9931407-B2 Silicon based drug conjugates and methods of using same BLINKBIO, INC. (US) 2018-04-03 — — US disclosed
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 — — US disclosed
WO-2016183359-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. (US) 2016-11-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT TYRO3 1424/4885DYRK1B 1207/4885IDH1 223/4885
US-20190290771-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT TYRO3 1424/4885DYRK1B 1207/4885IDH1 223/4885
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT TYRO3 1424/4885DYRK1B 1207/4885IDH1 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.